MedPath

Bazell Pharma AG

🇨🇭Switzerland
Ownership
Subsidiary
Established
2009-01-01
Employees
-
Market Cap
-
Website

Clinical Trials

1

Active:0
Completed:0

Trial Phases

1 Phases

Phase 2:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 2
1 (100.0%)

Pharmacokinetics, Efficacy, Tolerability and Safety of Different Budesonide Oral Gel Doses in Adults' Subjects of Both Genders With Eosinophilic Esophagitis (EoE)

Phase 2
Withdrawn
Conditions
Eosinophilic Esophagitis
Interventions
First Posted Date
2022-01-28
Last Posted Date
2024-08-23
Lead Sponsor
Bazell Pharma AG
Registration Number
NCT05214599

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.